Current Environment: Production

Warning

An important message to our patients and their caregivers.

We are here for you. Read more

Our researchers have been at the forefront of thalassemia research for decades. We are involved in a number of research initiatives aimed at improving thalassemia diagnosis and treatment including:

  • improving existing chelation therapies and investigating new ones
  • developing new ways to assess iron levels in the body
  • testing novel classes of medications that may decrease transfusion requirement
  • using stem cell transplants from matched donors to cure patients with transfusion-dependent thalassemia
  • developing gene therapy approaches for thalassemia major that would avoid the need to find a matched donor, because it’s the child’s own cells that are treated. One strategy we have developed, currently being studied in a clinical trial, uses gene editing to block the expression of the BCL11A gene. This restores the body’s ability to produce a fetal form of hemoglobin, compensating for loss of the adult form. We are also tracking patients receiving a new FDA-approved gene therapy called Zynteglo®.

Talk to Lesley

If this is a medical emergency, please dial 9-1-1. This application should not be used in an emergency. This chat is being transmitted via a secure connection.

Hi! My name is Lesley. I am a virtual agent programmed to help you. If you would like to speak to a live agent, please call 617-355-6000 or click here to log into your MyChildrens portal.

For questions regarding an upcoming appointment, doctor notes, or specific questions related to symptoms or a diagnosis, please call the department of clinic directly.

Quick links:

- Global Services
- Find a Doctor
- Find a Location
- Programs and Services
- Conditions and Treatments
- Request an Appointment